Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicentre Study To Assess The Efficacy And Tolerability Of PF-00592379 In Patients With Moderate To Severe Pain Due To Osteoarthritis

NCT00483977 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00483977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00483977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2 Week, Randomized, Double Blind, Placebo And Positive Controlled, Parallel Group, Multicentre Study To Assess The Efficacy And Tolerability Of PF-00592379 In Patients With Moderate To Severe Pain Due To Osteoarthritis
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2007
Completion date
December 31, 2007
Enrollment
113 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis